OncRef

Clinical Trial: NCT06660407

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

Status:

ACTIVE NOT RECRUITING

Phase:

Phase 2

Lead Sponsor:Mayo Clinic
Information Provided By:Mayo Clinic
Last Update Posted:2026-10-15

Study Overview

Brief Summary

This phase II trial tests the safety and effectiveness of the combination of grid radiation therapy and standard of care (SOC) immunotherapy in treating patients with stage IV non-small lung cancer (NSCLC). Conventional radiation therapy treatments typically deliver the same radiation dose to the entire tumor. Spatially fractionated radiation therapy or grid therapy is approved and a technique which permits the delivery of high doses of radiation to small regions of the tumor which can lead to enhanced tumor cell killing. Grid therapy has been shown to produce dramatic relief of severe symptoms, significant tumor regression (decrease in the size of a tumor), and above average local control rates often exceeding those expected with conventionally delivered radiation treatments, all with minimal associated toxicity. Immunotherapy has become combined into treating patients, which has led improvements in survival and quality of life. Immunotherapy is now the cornerstone of SOC therapy for stage IV NSCLC. Grid radiation therapy combined with immunotherapy may be safe and effective in treating patients with stage IV NSCLC.

Official Title

Grid Radiotherapy for Advanced Non-Small Cell Lung Cancer at the Time of Progression on Immune Checkpoint Inhibition

Conditions

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

Intervention / Treatment

  • Procedure: Biospecimen Collection
  • Procedure: Computed Tomography
  • Other: Immunotherapy
  • Radiation: Palliative Radiation Therapy
  • Radiation: Spatially-fractionated Radiation Therapy

Other Study ID Numbers

  • GMROR2221
  • 22-008589

Start Date (Actual)

2024-11-14

Primary Completion Date (Estimated)

2027-01-10

Study Completion Date (Estimated)

2027-01-10

Enrollment (Actual)

3

Study Type

Interventional

Phase

Phase 2